Hide Board Information

Show Board Information

NanoViricides Inc NNVC

Board Mod: Roofer2

Asst Mods:

Last Post: 06/02/2025 7:28:24 AM

Board Marks: 9

Posts Today: 0

Board Views Today: 62

1. NNVC Company Profile

    

2. NNVC Time & Sales

    

3. NNVC Recent News

    

4. NNVC Filings

    

5. NNVC Financials

    

6. NNVC Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	NNVC. climber.	PoemStone	07/20/2013 9:52:01 AM
7	Hopefully we will have news soon!	Roofer2	04/03/2013 4:58:24 PM
6	Waiting on FDA approval !	Roofer2	01/24/2013 10:40:52 PM
5	Is there an approximated time line for next news?	citrati	01/24/2013 7:22:42 PM
4	Ready for some action!	Roofer2	01/21/2013 11:33:48 PM
3	Ready for some current news on this one.	Roofer2	07/16/2012 3:51:56 PM
2	Nano patent being issued on May 8th, 2012.	Roofer2	05/07/2012 11:15:36 PM
1	NNVC, has exclusive rights on patents! Looking	Roofer2	03/28/2012 11:38:52 PM

Newer

Recent Articles

• Recap of the 27th Shanghai International Film Festival Awards
• Kaanch Network's Bold Steps Towards Transforming DeFi in 2025
• Wilson Blanchard Management's Successful WB CondoCon Event
• Martini Market $MRT Presale Hits 40% Milestone Within a Day
• Lawsuit Filed by Attorneys Against Universal Health Services
• Vaultro Finance Sees Surge in $VLT Presale on XRP Ledger
• Long Read Sequencing Market Anticipated to Surge to Nearly $7 Billion
• Discover How QuidMiner Revolutionizes Cloud Mining Today
• AIXA Miner Launches Innovative Free Cloud Mining Platform
• Perspective Therapeutics Advances Clinical Trial for Cancer Treatment
• Significant Efficacy of Vyepti in Treating Severe Migraines
• Eptinezumab's Impact on Severe Migraines: New Insights
• MetaVia Unveils Promising DA-1241 Data for Liver Health
• Eli Lilly's Orforglipron Shows Promise for Type 2 Diabetes
• Eptinezumab's Trial Results: A Breakthrough in Migraine Treatment
• Investors Can Step Forward in Vestis Corporation Legal Challenge
• New Insights on Eptinezumab's Effectiveness for Chronic Migraines
• Perspective Therapeutics Showcases Innovations in Cancer Treatment
• Shokz Introduces 5 Pro Athletes for Upcoming Endurance Run
• Bitcoin Solaris Prepares for Exciting Public Launch Next Month
• William Stern's Cardiff Transforms Working Capital Solutions
• MolecuLight Unveils Multimodal Imaging Innovations for Wound Care
• Innovative Diabetes Treatments Unveiled by Gan & Lee Pharmaceuticals
• AIXA Miner: Revolutionizing Passive Income in Crypto Space
• Teamsters Nurses Gear Up for Rally Ahead of Negotiations
• Class Action Lawsuit Opportunity for Compass Diversified Holdings Investors
• High Arctic Energy Services Reports Successful Annual Meeting
• Key Updates on Reckitt Benckiser Securities Class Action
• Understanding the Red Cat Holdings Class Action Lawsuit
• Legal Update: Compass Diversified Shareholder Lawsuit News
• Investor Alert: Key Information for Organon Shareholders
• Investors in Tempus AI - Know Your Rights and Options
• The China Fund, Inc. Moves Forward with Liquidation Plan
• DDB Worldwide Achieves Unmatched Recognition at Cannes Lions
• CHAI Transforms AI Performance with Innovative 4-Bit Model
• Join the Movement: Apple Class Action Lawsuit Opportunities
• Enzon and Viskase Announce Exciting Merger Agreement Plans
• Jane Silverstone Segal's Significant Share Acquisition in DAVIDsTEA
• enCore Energy Sells Shares to Strengthen Market Position
• Revolutionize Your Finances with the New XRP Mining App
• Novo Nordisk Reveals Exciting Amycretin Data at ADA 2025
• Novo Nordisk's Wegovy Trial Success: Weight Loss Breakthrough
• Innovative Stem Cell Therapies Offer Hope for Diabetes Care
• Breakthrough Study: Abbott's Program Enhances Diabetes Care
• Novo Nordisk's amycretin Moves to Phase 3 for Weight Management
• Medtronic's MiniMed 780G System Shows Significant Diabetes Benefits
• Water vs Diet Drinks: A Breakthrough in Diabetes Remission
• Automated Insulin Delivery Enhances Pregnancy Outcomes for Diabetics
• Innovative AI Models Transform Type 1 Diabetes Detection
• Breakthrough Medical Device Addresses Lipohypertrophy in Diabetes